JESSICA CAMPESTRINI: Open Payments
NPI 1851082796 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,836 in 65 payments from 22 companies in 2025. Trend: 2023 $353 · 2024 $2,035 · 2025 $1,836
Food & beverage: $1,736Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $583 |
| UCB, Inc. | 4 | $205 |
| Regeneron Healthcare Solutions, Inc. | 4 | $168 |
| PFIZER INC. | 11 | $144 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| GENZYME CORPORATION | 3 | $76 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| Biofrontera Inc. | 3 | $61 |
| ABBVIE INC. | 3 | $58 |
| Almirall LLC | 2 | $58 |
Products named: TREMFYA, DUPIXENT, Bimzelx, CIBINQO, COSENTYX, SKYRIZI, ADBRY, AMELUZ.
Industry payments across FL — which companies pay providers there.
